Skip to main content

Champion, University of Guelph Enter Research Collaboration on Pet Nutrition – Pet Age

Press release: Champion Petfoods

Champion Petfoods, maker of premium pet food brands ORIJEN and ACANA, has initiated a five-year grant to the University of Guelph in Guelph, Ontario – one of the world’s leading institutions in the field of veterinary medicine and animal science – to advance the study of pet food nutrition and train the next generation of scientific leaders in the pet food industry.

As part of the grant, the university has named Dr. Anna Kate Shoveller, an associate professor in the university’s Department of Animal Biosciences, as the inaugural Champion Petfoods chair in canine and feline nutrition.

“Our purpose at Champion is to earn pet lovers’ trust every day so pets thrive for a lifetime,” said Champion Petfoods chief executive officer Blaine McPeak. “Dedicated original research into pet nutrition is a foundational element that makes that possible. Our collaboration with the University of Guelph and Dr. Shoveller will help ensure that one of the world’s leading research teams has the resources to advance this vital work for the betterment of pets everywhere.”

The University of Guelph ranks first in Canada and fifth globally for the quality of its veterinary science program, plus first for the quality of its agricultural program – both of which inform the pet food industry. Dr. Shoveller, who earned a Ph.D. in nutrition and metabolism, is a veteran academic leader who has also amassed eight years working for leading companies in the pet food industry to advance the understanding of protein and energy. She is a past chair of the American Society of Animal Sciences’ Companion Animal Committee and has received numerous awards for her contributions to the advancement of dog and cat nutrition.

Champion’s grant will support the ongoing study of several topics in conjunction with other international research experts to expand the foundational knowledge of pet nutrition for the health of pets. In addition, this grant provides opportunity for training students in preparation for roles in the pet food and nutrition industry.

Champion Petfoods senior vice president of research, innovation and product development Jeff Johnston believes Champion’s support of Dr. Shoveller’s work will combine the strengths of the university and the company to drive innovation in current and future pet food products. Champion has a team of Pet Nutrition experts – including PhD-level nutritionists, food scientists and in-house and external veterinarians – who continually pursue the advancement of nutrition and wellness for pets. By partnering with Dr. Shoveller and the University of Guelph, the combined team will be able to continue applying the latest developments in animal nutrition to develop food that will help dogs and cats thrive.

“This is a commitment to the future of our industry,” Johnston said. “At Champion we focus exclusively on making the best, most nutritionalrsz_1orijen_feed_amazing-95_1 food to support a pet’s long-term health — the best there is today and the best that’s possible tomorrow. The science that will carry us into that future holds the promise to benefit not only Champion and the University of Guelph, but our entire industry and people everywhere who value the health of pets.”

Dr. Shoveller leads a team that also includes a select group of University of Guelph faculty from the Ontario Agricultural College, the Ontario Veterinary College and the College of Biological Science.

“Diet is part of a complex environment that helps determine a pet’s well-being, and the research we can pursue with Champion’s support will help us learn more about nutrition and the ways it interacts with other factors,” Dr. Shoveller said. “Champion is the first Canadian pet food company to make a commitment like this to the future of animals’ well-being. My colleagues and I are grateful for this partnership and eager to begin the new avenues of work it makes possible.”



from WordPress https://ift.tt/3ogUMTl
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Covid-19 News: F.D.A. Panel to Meet This Week on Moderna and J. & J. Boosters – The New York Times

Image A vaccination site in Spain, where the health regulator approved the use of third Covid-19 vaccination shots for immunocompromised people in September. Credit… Zowy Voeten/Getty Images Severely or moderately immunocompromised people who have been vaccinated should be offered an additional dose of the seven coronavirus vaccines the World Health Organization has authorized, an advisory committee recommended on Monday. People whose immune systems are diminished should get another shot if they initially received vaccines made by Pfizer-BioNTech, Moderna, AstraZeneca, the Serum Institute of India, Johnson & Johnson, Sinopharm and Sinovac, members of the Strategic Advisory Group of Experts on Immunization told reporters on a call on Monday. Dr. Alejandro Cravioto, the committee’s chair, said that people with compromised immune systems “need a third dose as an additional priming process so that they’re fully protected.” The officials also recommended a third vaccine ...
Post a Comment
Read more

COVID-19 live updates: Pfizer to seek approval for adult boosters, source says – WOKV

NEW YORK — As the COVID-19 pandemic has swept the globe, more than 5 million people have died from the disease worldwide, including over 756,000 Americans, according to real-time data compiled by Johns Hopkins University’s Center for Systems Science and Engineering. Just 68.4% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the U.S. Centers for Disease Control and Prevention. Latest headlines: -US surgeon general releases guide to combating COVID-19 vaccine misinformation -Pfizer to request OK for boosters to all adults: Source -US reopens borders to vaccinated travelers Here’s how the news is developing. All times Eastern. Nov 09, 2:42 pm Aaron Rodgers: ‘To anybody who felt misled … I take full responsibility’ Green Bay Packers quarterback Aaron Rodgers says he takes full responsibility for anyone who felt mislead by his comments about his vaccination status. “I do realize I am a role model,” Rodgers said on “The Pat McAfee Show” Tu...
Post a Comment
Read more

The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday. – The New York Times

Coronavirus Updates Aug. 21, 2021 Updated  Aug. 21, 2021, 10:11 p.m. ET Aug. 21, 2021, 10:11 p.m. ET Pfizer vaccines were administered at the St. John Chrysostom Catholic Parish in The Bronx on Sunday. Credit… James Estrin/The New York Times The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time. An F.D.A. spokeswoman declined to comment. The agency had recently set an unofficial deadline for approval of around Labor Day. The approval is expected to ...
Post a Comment
Read more